Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for Diethylpropion (compound)


PubChem
Name: Diethylpropion
PubChem Compound ID: 7029
Description: A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p2290)
Molecular formula: C13H19NO
Molecular weight: 205.296 g/mol
Synonyms:
Obesitex; Silutin; Neobes; Propiophenone, 2-(diethylamino)-; 2-(Diethylamino)-1-phenyl-1-propanone; Amphepramon; DEA No. 1610; alpha-Diethylaminopropiophenone; Adiposon; Dobesin.
show more »
DrugBank
Identification
Name: Diethylpropion
Name (isomeric): DB00937
Drug Type: small molecule
Description: A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p2290)
Synonyms:
Diethylcathinone; Amfepramone Hydrochloride; DEA No. 1610; alpha-Diethylaminopropiophenone; Amphepramonum hydrochloride; Diethylpropion HCL; Diethylpropione hydrochloride; Diethylpropion Hydrochloride; Anfepramona [INN-Spanish]; alpha-Benzoyltriethylamine.
show more »
Brand: Tenuate, Amphepramone, Moderatan, Tenuate hydrochloride, Tepanil Ten-tab, Dobesin, Magrene, Frekentine, Regenon hydrochloride, Neobes, Nopropiophenone, Regenon, Keramik, Tylinal, Tenuate Dospan, Keramin, Tepanil, Modulor, Obesitex, Silutin, Anorex, Amfepramon, Derfon, Amfepramone, Adiposon, Danylen, Prefamone, Reginon, Anfamon, Parabolin, Cegramine, Amphepramon
Category: Anorexigenic Agents, Appetite Depressants, Stimulants
CAS number: 134-80-5
Pharmacology
Indication: Used in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.
Pharmacology: Diethylpropion is a sympathomimetic stimulant drug marketed as an appetite suppressant. Chemically, it is the N,N-diethyl analog of cathinone. Its mechanism of action is similar to other appetite suppressants such as sibutramine, phentermine and dextroamphetamine.
Mechanism of Action:
Diethylpropion is an amphetamine that stimulates neurons to release or maintain high levels of a particular group of neurotransmitters known as catecholamines; these include dopamine and norepinephrine. High levels of these catecholamines tend to suppress hunger signals and appetite. Diethylpropion (through catecholamine elevation) may also indirec...
show more »
Absorption: Diethylpropion is rapidly absorbed from the GI tract after oral administration.
Biotransformation: Extensively metabolized through a complex pathway of biotransformation involving N-dealkylation and reduction. Many of these metabolites are biologically active and may participate in the therapeutic action of diethylpropion.
Route of elimination: Diethylpropion is rapidly absorbed from the GI tract after oral administration and is extensively metabolized through a complex pathway of biotransformation involving N-dealkylation and reduction. Diethylpropion and/or its active metabolites are believed to cross the blood-brain barrier and the placenta. Diethylpropion and its metabolites are excreted mainly by the kidney.
Half Life: Using a phosphorescence assay that is specific for basic compounds containing benzoyl group, the plasma half-life of the aminoketone metabolites is estimated to be between 4 to 6 hours.
Toxicity: The reported oral LD50 for mice is 600 mg/kg, for rats is 250 mg/kg and for dogs is 225 mg/kg. Manifestation of acute overdosage include restlessness, tremor, hyperreflexia, rapid respiration, confusion, assaultiveness, hallucinations, and panic states.
Affected organisms: Humans and other mammals
Interactions
Food interaction:
Take without regard to meals.
Drug interaction:
MesoridazineDecreased anorexic effect, may increase psychotic symptoms
ChlorpromazineDecreased anorexic effect, may increase psychotic symptoms
MethdilazineDecreased anorexic effect, may increase psychotic symptoms
FluvoxamineRisk of serotoninergic syndrome
ThiethylperazineDecreased anorexic effect, may increase psychotic symptoms
show more »

Targets